Tag: Bayer

Bayer AG is a German multinational chemical, pharmaceutical and life sciences company. It is headquartered in Leverkusen, where its illuminated sign is a landmark. Bayer’s primary areas of business include human and veterinary pharmaceuticals; consumer healthcare products; agricultural chemicals and biotechnology products; and high value polymers.

Bayer to Donate Medicines and Money with a Total Value EUR 1.5 Million

Bayer is donating medicines and additional financial aid worth a total of approximately EUR 1.5 million to support the population affected by the outbreak of the novel coronavirus in China. The donati...

Bayer’s New “Tumor-Agnostic” Cancer Drug Failed to Pick up Endorsements in England...

In a one-two punch for Bayer, cost watchdogs in England and Germany rejected the company’s new “tumor-agnostic” cancer drug Vitrakvi because of its price and “limitations” in its supporting data. E...

WuXi Biologics Continue to Expand Worldwide Capacity

WuXi Biologics, a leading global open-access biologics technology platform company offering end-to-end solutions for biologics discovery, development and manufacturing, and Bayer jointly announced an ...

SidekickHealth Begun Strategic Partnership with Bayer

bayer
Nordic digital therapeutics company SidekickHealth has begun a strategic partnership with German pharma Bayer to provide a digital medication management and lifestyle change platform to patients suffe...

Bayer Ready to Develop Oral NRT with Children’s Hospital of Philadelphia

Bayer has entered into a three-year collaboration agreement with Children's Hospital of Philadelphia (CHOP) for the discovery and development of small molecules (SMOLs) for a first-in-class oral non...

Bayer Submitted Application to EMA to Extend Xarelto Marketing Authorization

Bayer has submitted an application to the European Medicines Agency (EMA) to extend the Xarelto marketing authorization, making it available for children up to 17 years old with confirmed VTE, includi...

Bayer Announced Positive Results of Phase III Study of Investigational Drug Vericiguat

clinical-trials
Bayer announced that the Phase III study VICTORIA (VerICiguaT glObal study in patients with heart failure with Reduced ejectIon frAction) evaluating the efficacy and safety of investigational vericigu...

Bayer AG Successfully Placed Hybrid Capital with €1.75bn

bayer
Bayer AG successfully placed hybrid capital with a total volume of 1.75 billion euros. The issue comprises two tranches and exclusively targets institutional investors. It was more than five times ove...

Bayer Announced Sale of Dr. Scholl’s™ Business to Yellow Wood Partners

Bayer announced the completion of the sale of the Dr. Scholl’s™ business to Yellow Wood Partners for a purchase price of 585 million U.S. dollars. Dr. Scholl’s™ is an iconic, one-of-a-kind brand, w...

Bayer Sales Increased by 5.4%

Bayer has made progress in all key areas and is on track both operationally and strategically. “Bayer had a successful third quarter,” Werner Baumann, Chairman of the Board of Management, said durin...

Bayer Animal Health GmbH and VLPbio Signed Global Collaboration Agreement

Bayer Animal Health GmbH and VLPbio – The Vaccines Company S.L. have signed a global collaboration agreement to discover and develop a new generation of immunotherapeutic solutions that address the hi...

FDA Approved Xarelto™ for Venous Thromboembolism Prevention

Bayer AG and its development partner Janssen Research & Development, LLC announced that the U.S. Food and Drug Administration (FDA) has approved rivaroxaban (Xarelto™) for the prevention of venous...

Bayer’s Otic Solution Neptra® Received Positive Opinion of EMA’s CVMP

Bayer's Otic Solution Neptra® (florfenicol, terbinafine hydrochloride, mometasone furoate) has now received, the positive opinion of the Committee for Medicinal Products for Veterinary Use (CVMP) of t...

Bayer Signed Collaboration Agreements with 11 Digital Health Startups

Bayer announced that the company has signed collaboration agreements with eleven digital health startups. As part of the program, Bayer will support these startup companies aiming for longer-term c...

Bayer Launched LifeHub UK to Accelerate Disease Detection and Drug Discovery

bayer
Bayer launched LifeHub UK to accelerate and optimize disease detection and data-driven drug discovery by developing artificial-intelligence-enabled imaging solutions. The new hub is the seventh pillar...

Bayer and Partners Launched Joint Lab to Research New Drug Candidates to Treat Chronic Lung Diseases...

Bayer and Partners HealthCare’s founding members Brigham and Women’s Hospital (BWH) and Massachusetts General Hospital (MGH) announced the launch of a joint lab to research new drug candidates to trea...